GCMS fingerprints and phenolic extracts of inhibit key enzymes associated with type 2 diabetes.

Objectives: Inhibition of carbohydrate digestion enzymes (α-amylase and α-glucosidase) has been reported in studies as a therapeutic approach for the management or treatment of type 2 diabetes mellitus, owing to its potential to decrease postprandial hyperglycemia. The anti-diabetic potential of (also known as garlic) against diabetes mellitus has been established. Therefore, in this study, we assessed the antidiabetic potential of using enzyme assays after which we explored computational modelling approach using the quantified GC-MS identities to unravel the key bioactive compounds responsible for the anti-diabetic potential.